Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2022-07-22 00:00:00 ET · period of report 2022-07-20 · accession 0001104659-22-082020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-22 | 2022-07-20 | TGTX | Hoberman Kenneth | Dir | A - Grant | $0.00 | +43.7K | 222.7K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-20 | A | A | 43,732 | $0.00 | 222,685 | D | — | — | (F1) Reflects a grant of restricted shares that will vest on June 15, 2023. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |